Phase II trial of low-dose cyclo-phosphamide, leucovorin, high-dose 5-fluorouracil 24-hour continuous infusion and tamoxifen in advanced biliary tract cancer
Open Access
- 1 June 2000
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 11 (6), 762-763
- https://doi.org/10.1023/a:1008368611993
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: results of a randomized trial in patients with advanced colorectal cancer.Journal of Clinical Oncology, 1998
- Continuous infusion of chemotherapy: focus on 5-fluorouracil and fluorodeoxyuridine.International Journal of Clinical Pharmacy, 1998
- Comparison of 5-Fluorouracil, Doxorubicin and Mitomycin C with 5-Fluorouracil Alone in the Treatment of Pancreatic-Biliary CarcinomasOncology, 1994
- Nonspecific Immunostimulation with Low Doses of Cyclophosphamide (LDCY), Thymostimulin, and Echinacea Purpurea Extracts (Echinacin) in Patients with Far Advanced Colorectal Cancers: Preliminary ResultsCancer Investigation, 1992
- Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinomaCancer, 1991
- Eastern cooperative oncology group experience with chemotherapy for inoperable gallbladder and bile duct cancerCancer, 1984